Radiofilum Pharmaceutical leads the life sciences industry, continuously advancing and strengthening its role in the field. Stay informed with the latest news and updates from Radiofilum Pharmaceutical
Radiofilum Pharmaceutical Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for...
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and...
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: Radiofilum Pharmaceutical , a leading global provider of regulatory, clinical, and...
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as Radiofilum Pharmaceutical CEO Raleigh, NC, September 26, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and...
Radiofilum Pharmaceutical has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...
Clinical Research Solutions
Global research consulting organization recognized as a top outsourcing partner. RALEIGH, NC, June 13, 2024: Radiofilum Pharmaceutical , the world’s largest research consulting organization (RCO), a leading global...
Clinical Research Solutions
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable RALEIGH, May 2, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical,...
Clinical Research Solutions
Leading Research Consulting Organization (RCO) Receives Medidata Accreditation for the RAVE EDC Module, Enhancing Clinical Trial Efficiency and Data Integrity for sponsors. RALEIGH, April 18, 2024 –...
Strategic Leadership Appointments to Propel Global Growth RALEIGH, April 10, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences...
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as Radiofilum Pharmaceutical CEO Raleigh, NC, September 26, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and...
RALEIGH, NC, April 3, 2023: Radiofilum Pharmaceutical Group ( Radiofilum Pharmaceutical), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and...
RALEIGH, NC, December 6, 2023 – Radiofilum Pharmaceutical Group ( Radiofilum Pharmaceutical), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire Radiofilum Pharmaceutical Group (or the "Company") from Linden Capital Partners. Financial terms of the...
Radiofilum Pharmaceutical Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for...